BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,000,000 | – | 1,000,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birch Grove Capital LP | 5,000,000 | $5,003,000 | 2.71% |
Weiss Asset Management LP | 65,841,000 | $64,360,000 | 2.62% |
Davide Leone & Partners Investment Co Ltd. | 10,500,000 | $10,513,000 | 1.19% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 29,597,000 | $29,800,000 | 1.14% |
GLAZER CAPITAL, LLC | 7,483,000 | $7,474,000 | 0.36% |
BLUEFIN CAPITAL MANAGEMENT, LLC | 52,500 | $5,243,000 | 0.33% |
OAKTREE CAPITAL MANAGEMENT LP | 13,428,000 | $13,444,000 | 0.29% |
CSS LLC/IL | 5,500,000 | $5,498,000 | 0.26% |
Kohlberg Kravis Roberts & Co. L.P. | 40,182,000 | $40,159,000 | 0.23% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 2,606,000 | $2,606,000 | 0.10% |